A prospective open-label Phase 2 study of METYRAPONE as a preoperative treatment in patients with ACTH-independent Cushing’s syndrome due to adrenal adenoma. - METYX01 A prospective open-label Phase 2 study of METYRAPONE as a preoperative treatment in patients with AC ...